Meetings to be held April 10-11 hosted by Oppenheimer.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on INCY:
- Incyte granted orphan status for myelofibrosis treatment
- Incyte announces Japanese MHLW approval of Pemazyre
- Incyte upgraded to Market Perform at SVB after ruxolitinib XR CRL, Zynz approval
- Incyte upgraded to Market Perform from Underperform at SVB Securities
- BofA sees minimal near-term impact on Incyte from ruxolitinib ER CRL
Questions or Comments about the article? Write to editor@tipranks.com